Monitoring of Activated Coagulation Time with Kaolin vs. Celite Activator in Cardiac Surgical Patients with Aprotinin

Aprotinin을 투여한 개심술 환자에서 Kaolin과 Celite Activator를 이용한 Activated Coagulation Time(ACT) 측정의 비교

  • Kim, Joung-Taek (Department of Thoracic and Cardiovascular Surgery, Inha University Hospital) ;
  • Sun, Kyung (Department of Thoracic and Cardiovascular Surgery, Inha University Hospital) ;
  • Lee, Choon-Soo (Department of Anesthesiology, Inha University Hospital) ;
  • Baik, Wan-Ki (Department of Thoracic and Cardiovascular Surgery, Inha University Hospital) ;
  • Cho, Sang-Rock (Department of Thoracic and Cardiovascular Surgery, Inha University Hospital) ;
  • Kim, Hyun-Tae (Department of Thoracic and Cardiovascular Surgery, Inha University Hospital) ;
  • Kim, Hea-Sook (Department of Thoracic and Cardiovascular Surgery, Inha University Hospital) ;
  • Park, Hyun-Hee (Department of Thoracic and Cardiovascular Surgery, Inha University Hospital) ;
  • Kim, Kwang-Ho (Department of Thoracic and Cardiovascular Surgery, Inha University Hospital)
  • 김정택 (인하대학교 의과대학부속병원 흉부외과) ;
  • 선경 (인하대학교 의과대학부속병원 흉부외과) ;
  • 이춘수 (인하대학교 의과대학부속병원 마취과) ;
  • 백완기 (인하대학교 의과대학부속병원 흉부외과) ;
  • 조상록 (인하대학교 의과대학부속병원 흉부외과) ;
  • 김현태 (인하대학교 의과대학부속병원 흉부외과) ;
  • 김혜숙 (인하대학교 의과대학부속병원 흉부외과) ;
  • 박현희 (인하대학교 의과대학부속병원 흉부외과) ;
  • 김광호 (인하대학교 의과대학부속병원 흉부외과)
  • Published : 1998.09.01

Abstract

Background: High-dose aprotinin has been reported to enhance the anticoagulant effects of heparin during cardiopulmonary bypass ; hence, som authors have advocated reducing the dose of heparin in patients treated with aprotinin. Material and Method: The ACT was measured before, during and after cardiopulmonary bypass, with Hemochron 801 system using two activators of celite(C-ACT) and kaolin(K- ACT) as surface activator. From June, 1996 to February, 1997, 22 adult patients who were scheduled for elective operation were enrolled in this study. Result: The ACT without heparin did not differ between C-ACT and K-ACT. At 30 minutes after anticoagulation with heparin and cardiopulmonary bypass, the average C-ACT was 928${\pm}$400 s; K-ACT was 572${\pm}$159s(p<0.05). After administration of protamine, C-ACT was 137${\pm}$26 s; K-ACT was 139${\pm}$28s, which were not statistically significant. Conclusion: Our results showed that the significant increase in the ACT during heparin- induced anticoagulation in the presence of aprotinin was due to the use of celite as surface activator, rather than due to enhanced anticoagulation of heparin by aprotinin. We conclude that the ACT measured with kaolin provides better monitoring of cardiac surgical patients treated with high dose aprotinin than does the ACT measured with celite. The patients treated with aprotinin should receive the usual doses of heparin.

개심수술에서 Aprotinin에 의한 ACT가 연장되는가를 알아보기 위해 서로 다른 표면 촉매제인 kaolin (K-ACT)과 celite(C-ACT)를 이용하여 동시에 측정 비교하였다. 개심수술을 받은 22명의 성인을 대상으로 하여 Hemocron 8000 system을 이용하여 동시에 ACT를 측정 하였는데 aprotinin과 heparin 투여 전(Phase I), Aprotinin투여 후 heparin 투여 전(Phase II), heparin투여 5분 후(Phase III), haparin투여 30분 후(Phase IV), heparin투여 60분 후(Phase V), heparin투여 90분 후(Phase VI), protamin투여 30분 후(Phase VII)에 각각 측정하였다. Phase I, II, III에 두 군간에 차이가 없었으나 heparin투여 30분 후에는 C-ACT가 928$\pm$400초 K-ACT가 572$\pm$159초였고 60분 후에는 C-ACT가 888$\pm$254초 K-ACT가 535$\pm$186초 90분 후에는 C-ACT가 686$\pm$141초 K-ACT가 484$\pm$54초로 K-ACT에 비해 C-ACT가 통계학적으로 의의있게 증가하였다. 그러나 protamin투여 후에는 C-ACT가 137$\pm$26초 K-ACT가 139$\pm$28초로 두군간에 차이가 없었다. 이상의 결과에서 aprotinin투여 후 ACT는 연장이 되는 것이 아니라 activator로 celite를 사용했기 때문인 것으로 생각된다. 결론적으로 aprotinin을 투여한 개심수술에서 정확한 ACT수준을 측정하기 위하여 celite activator보다 kaolin activator를 사용해야 하며 heparin은 보통용량을 투입하여야 할 것으로 생각된다.

Keywords

References

  1. 대한마취과학회지 v.30 심장수술시 Aprotinin 사용이 Kaolin 및 Celite Activated Clotting Time에 미치는 영향 조대현;함병문
  2. Ann Thorac Surg v.55 Aprotinin in Perspective Westaby S.;FRCS
  3. J Thorac Cardiovasc Surg v.101 Effect of introperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation Havel M;Teufelsbauser H;Knobl P(et al.)
  4. Anesthesiology v.83 High dose aprotinin enhances anti-coagulation Dietrich W;Dilthey G;Jochum M(et al.)
  5. J Thorac Cardiovasc Surg v.100 Increased anticogulation during cardiopulmonary bypass by oprotinin Andre AE;Melvin CN;Wilem O(et al.)
  6. Anesthesiology v.77 Monitoring of heparin-induced anticoagulation with kaolin activated coltting time in cardiac surgical patients treated with aprotinin Wang JS;Lin CY;Hung WT;Karp R
  7. Thorac Cardiovasc Surg v.42 Celite and Kaolin produce differing activated clotting times during cardiopulmonary bypass under aprotinin therapy Feindt P;Seyfert T;Volkmer I;Sraub U;Gams E
  8. J. Cardiothoracic & Vasc Anesth v.8 no.2 Alternative perioperative anticoagulation monitoring during cardiopulmonary bypass in aprotinin treated patients Huyzen R;Harde MP;Heut G;Boonstra PW(et al.)
  9. Ann Thorac Surg v.55 Effects of aprotinin on anticoagulant monitoring:Implications in cardiovascular surgery Najman D;Walenga J;Fareed J;Pifarre R
  10. J Thorac Cardiovasc Surg v.104 In vitro effects of aprotinin on activated clotting time measured with different activators Wang JS;Lin CY;Hung WT(et al.)
  11. Ann Thorac Surg v.55 Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest Sundt TM;Kuochoukos NT;Saffitz JE(et al.)